79
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Paraneoplastic syndrome: Subacute cerebellar degeneration in Hodgkin's disease

, , &
Pages 819-822 | Received 11 Nov 2006, Accepted 09 Dec 2006, Published online: 01 Jul 2009

References

  • Darnell R B, Posner J B. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349: 1543–1554
  • Candler P M, Hart P E, Barnett M, Weil R, Rees J H. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry 2004; 75: 1411–1415
  • Gultekin S H, Rosenfeld M R, Voltz R, Eichen J, Posner J B, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481–1494
  • Graus F, Delattre J Y, Antoine J C, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135–1140
  • Duncan M M, Cobos M E, Maccario M. Paraneoplastic degeneration due to Hodgkin's disease. West J Med 1989; 150: 463–465
  • Darnell R B. Onconeuronal antigens and paraneoplastic neuralgic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci USA 1996; 93: 4529–4536
  • Bernal F, Shamsíli S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003; 60: 230–234
  • Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000; 342: 21–27
  • Scheid R, Voltz R, Briest S, Kluge R, von Cramon D Y. Clinical insights into paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 2006; 77: 529–530
  • Albert M L, Austin L M, Darnell R B. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 2000; 47: 9–17
  • Keime-Guibert F, Graus F, Fleury A, Rere R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000; 68: 479–482
  • Shamsíli S, Grefkens J, De Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003; 126: 1409–1418
  • De Beukelaar J W, Sillevis Smitt P A. Managing paraneoplastic neurological disorders. Oncologist 2006; 11: 292–305

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.